SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-19-002534
Filing Date
2019-02-14
Accepted
2019-02-14 15:42:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0219woodford_evofembio.htm SC 13G 55611
  Complete submission text file 0001213900-19-002534.txt   57397
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Subject) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88576 | Film No.: 19605566
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O WOODFORD INVESTMENT MANAGEMENT 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN
Business Address C/O WOODFORD INVESTMENT MANAGEMENT 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN 441865809041
Woodford Patient Capital Trust Plc (Filed by) CIK: 0001729720 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G